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Abstract: Reduced fat dairy products are generally recommended for adults and children over
the age of two years. However, emerging evidence suggests that dairy fat may not have
detrimental health effects. We aimed to investigate prospective associations between consumption
of regular versus reduced fat dairy products and cardiometabolic risk factors from early to late
adolescence. In the West Australian Raine Study, dairy intake was assessed using semi-quantitative
food frequency questionnaires in 860 adolescents at 14 and 17-year follow-ups; 582 of these also had
blood biochemistry at both points. Using generalized estimating equations, we examined associations
with cardiometabolic risk factors. Models incorporated reduced fat and regular fat dairy together
(in serves/day) and were adjusted for a range of factors including overall dietary pattern. In boys,
there was a mean reduction in diastolic blood pressure of 0.66 mmHg (95% CI 0.23–1.09) per serve
of reduced fat dairy and an independent, additional reduction of 0.47 mmHg (95% CI 0.04–0.90)
per serve of regular fat dairy. Each additional serve of reduced fat dairy was associated with a 2%
reduction in HDL-cholesterol (95% CI 0.97–0.995) and a 2% increase in total: HDL-cholesterol ratio
(95% CI 1.002–1.03); these associations were not observed with regular fat products. In girls, there
were no significant independent associations observed in fully adjusted models. Although regular
fat dairy was associated with a slightly better cholesterol profile in boys, overall, intakes of both
regular fat and reduced fat dairy products were associated with similar cardiometabolic associations
in adolescents.
Keywords: dairy; regular fat; reduced fat; low fat; saturated fat; dairy fat; metabolic; adolescent;
blood pressure; cholesterol; Raine study
1. Introduction
Approximately 60%–70% of fat in dairy products such as milk, yoghurt and cheese is saturated
fat. Dairy fat is also a source of fat-soluble vitamins and unsaturated fats, including omega-3s.
To reduce intakes of saturated fat, dietary guidelines typically recommend choosing mostly reduced
fat, rather than regular fat (also known as whole or full fat) dairy products from early childhood [1–3].
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These guidelines are generally thought to be based on two presumptions: firstly, that the lower energy
content of reduced fat products decreases risk of excessive weight gain; and secondly, that the lower
saturated fat content decreases risk of cardiometabolic disease [4].
Emerging evidence suggests that despite being high in saturated fat, regular fat dairy products
may not contribute to development of obesity or cardiometabolic disease. A systematic review of dairy
consumption and obesity in prospective adult cohort studies found that reduced fat dairy products
were no more beneficial for weight status than regular fat dairy products, with some studies suggesting
that the reverse may be true [5,6]. Similarly, inverse associations with regular fat but not reduced
fat dairy and adiposity measures have been reported in children [7,8]. There is also little evidence
that higher intakes of regular fat dairy foods increases risk of mortality [9] or chronic disease risk,
including metabolic syndrome [10–12]. A systematic review of observational studies published in 2013
concluded that existing evidence did not support the hypothesis that dairy fat or regular fat dairy
foods contribute to obesity or cardiometabolic disease risk [13].
Few studies have investigated associations between dairy intake, particularly regular compared
with reduced fat dairy, and cardiometabolic risk factors in adolescence. Despite adolescence being
a critical period of growth and development [14], we have previously reported that intake of dairy
products tends to decrease through this period [15]. This may be due in part to avoidance of regular
fat dairy products. Evidence suggests that Australian adolescents are failing to consume the 3.5 serves
of dairy recommended daily to meet calcium requirements [1,15,16]. If research shows health effects
are similar between regular fat and reduced fat dairy products, the enhanced palatability of regular fat
products may potentially improve intakes.
We aimed to investigate the association between cardiometabolic risk factors and regular and
reduced fat dairy intake from early to late adolescence. We hypothesized that intake of regular fat
dairy products would not be associated with increased cardiometabolic risk compared with reduced
fat dairy products.
2. Subjects and Methods
2.1. Subjects
Participants were adolescents in the Western Australian Pregnancy Cohort (Raine) Study.
This population-based cohort enrolled 2900 women at 18 weeks gestation between 1989–1991,
with 2868 live-born babies followed up at regular intervals [17]. In this study, we report pooled
data from 14-year (2003–2006) and 17-year (2006–2009) follow-ups. Ethics committees at King Edward
Memorial Hospital and Princess Margaret Hospital for Children approved the research, and adolescents
and their parents or guardians gave informed written consent to participate.
2.2. Dietary Intake Assessment
Dietary data were collected at the 14-year (n = 1631) and 17-year (n = 1009) follow-ups using
a 212-item semi-quantitative food frequency questionnaire (FFQ) developed by the Commonwealth
Scientific and Industrial Research Organization (CSIRO) [18], as previously detailed [19]. The FFQ
was based on an Australian food composition database [20] and modified to include snacks and
beverages typically eaten by adolescents. It has been shown to reasonably rank intakes when validated
against a 3-day food diary in a sub-group of this same cohort [21]. Completed FFQs were checked by
a research nurse and forwarded to CSIRO for data entry and verification. We used serves/day of dairy
as a measurement unit rather than grams/day, due to inherent differences across the range of dairy
products consumed—for example, 40 g of cheese is nutritionally different to 40 g of milk. Based on the
Australian Guide to Healthy Eating [22], we calculated total serves based on 300 mg calcium/serve
(range 252–350 mg) [15]—for example, one serve of cheese is 40 g, whereas one serve of milk is
250 mL. In addition to dairy products specified in the FFQ (including butter, drinks, milk on cereal,
cheese, cream, yoghurt, ice cream, and custard), contributions to milk, butter and cheese categories
Nutrients 2016, 8, 22 3 of 16
were extracted from mixed dishes, such as milk puddings, mornay dishes and pizza. To estimate
dairy product contributions from these mixed dishes, recipes were standardised against “Cookery the
Australian Way” [23] and the “Taste Australia” website [24], and entered into FoodWorksr Professional
2009 dietary software (Xyris Software Pty Ltd, Brisbane, Australia). Dairy content was then determined
and added to the applicable category. Dairy products were categorised as either regular or reduced
fat based on categories specified in the FFQ, or through searching brand names when specified using
FoodWorks analysis or nutrient information panels. Fat content was then compared for that product
with industry standards to determine whether it was regular or reduced fat (see the footnote of
Table 1). Some non-core dairy products, such as butter, are often not included in studies of dairy intake.
However, we chose to include all sources of dairy, particularly high fat sources, because evidence
suggests that fat from dairy products, including butter, may have different health effects to other foods
high in saturated fat [9].
Table 1. Population characteristics, dietary intakes and cardiometabolic factors of Raine Study
adolescents at 14- and 17-year follow-ups.
Mean ˘ SD or n (%)
Girls (n = 461)
p
Boys (n = 399)
pFollow-up Year Follow-up Year
14 17 14 17
Age (yr) 14.0 ˘ 0.2 17.0 ˘ 0.2 <0.001 14.0 ˘ 0.2 16.9 ˘ 0.2 <0.001
Height (m) 1.62 ˘ 0.10 1.66 ˘ 0.06 <0.001 1.67 ˘ 0.09 1.79 ˘ 0.07 <0.001
Weight (kg) 56.3 ˘ 11.6 63.0 ˘ 13.0 <0.001 57.8 ˘ 13.8 71.9 ˘ 14.4 <0.001
Waist to height ratio 0.45 ˘ 0.06 0.46 ˘ 0.06 <0.001 0.453 ˘ 0.062 0.448 ˘ 0.057 0.005
BMI (kg/m2) 21.3 ˘ 4.00 22.9 ˘ 4.31 <0.001 20.6 ˘ 3.87 22.4 ˘ 3.92 <0.001
Aerobic fitness a 98.6 ˘ 19.5 102.3 ˘ 25.5 0.002 126.4 ˘ 31.3 158.3 ˘ 40.7 <0.001
Family’s characteristics
Maternal age (yr) 29.4 ˘ 5.7 NA 30.0 ˘ 5.1 NA
Single parent family 83 (18.0) 98 (21.3) <0.001 51 (12.8) 72 (18.0) <0.001
Annual family income ($AUD)
Up to 35,000 100 (21.7) 60 (13.0)
<0.001
71 (17.8) 46 (11.5)
<0.00135,001–70,000 165 (35.8) 107 (23.2) 138 (34.6) 90 (22.6)
70,001 and over 189 (41.0) 253 (54.9) 183 (45.9) 247 (61.9)
Dietary variables
Ever breastfed (yes) 410 (88.9) NA 353 (88.5) NA
Energy (MJ/day) 8.75 ˘ 2.77 8.00 ˘ 2.64 <0.001 10.18 ˘ 2.84 10.90 ˘ 3.46 <0.001
Total dairy (g/day) 439 ˘ 279(median 394)
350 ˘ 247
(median 303) <0.001
621 ˘ 350
(median 567)
570 ˘ 372
(median 495) 0.009
Regular fat dairy (g/day) 228 ˘ 228(median 132)
153 ˘ 194
(median 70) <0.001
358 ˘ 373
(median 205)
314 ˘ 337
(median 160) 0.007
Reduced fat dairy b (g/day)
211 ˘ 266
(median 104)
197 ˘ 218
(median 125) 0.24
263 ˘ 301
(median 130)
257 ˘ 321
(median 130) 0.70
Total dairy serves
(calcium eq serves/day)
2.18 ˘ 1.24
(median 1.99)
1.85 ˘ 1.24
(median 1.63) <0.001
2.92 ˘ 1.53
(median 2.67)
2.80 ˘ 1.71
(median 2.45) 0.18
Regular fat dairy serves
(calcium eq serves/day)
1.14 ˘ 1.05
(median 0.78)
0.84 ˘ 1.04
(median 0.42) <0.001
1.69 ˘ 1.70
(median 1.06)
1.55 ˘ 1.58
(median 1.00) 0.06
Reduced fat dairy serves
(calcium eq serves/day)
1.04 ˘ 1.24
(median 0.54)
1.01 ˘ 1.06
(median 0.73) 0.56
1.23 ˘ 1.35
(median 0.65)
1.25 ˘ 1.49
(median 0.63) 0.70
Calcium (mg/day) 1033 ˘ 480(median 938)
913 ˘ 465
(median 855) <0.001
1295 ˘ 541
(median 1226)
1291 ˘ 656
(median 1174) 0.90
Protein (g/day) 85.5 ˘ 27.3 79.2 ˘ 28.8 <0.001 101 ˘ 28.6 107 ˘ 38.0 0.002
Carbohydrate (g/day) 253 ˘ 87 228 ˘ 76 <0.001 292 ˘ 86 305 ˘ 102 0.02
Total fat (g/day) 82.7 ˘ 29.6 70.8 ˘ 28.7 <0.001 96.3 ˘ 32.8 99.4 ˘ 38.5 0.12
Polyunsat fat (g/day) 12.9 ˘ 6.12 10.4 ˘ 5.67 <0.001 14.2 ˘ 6.89 13.3 ˘ 7.07 0.04
Monounsat fat (g/day) 28.5 ˘ 10.3 24.1 ˘ 9.74 <0.001 33.3 ˘ 11.7 34.0 ˘ 13.2 0.31
Saturated fat (g/day) 35.8 ˘ 14.5 30.7 ˘ 14.4 <0.001 42.7 ˘ 16.6 44.6 ˘ 19.6 0.05
Healthy diet pattern score c 0.05 ˘ 0.85(median ´0.10)
0.06 ˘ 0.88
(median ´0.08) 0.76
´0.01 ˘ 0.88
(median ´0.38)
´0.07 ˘ 0.89
(median ´0.41) 0.14
Western diet pattern score c ´0.21 ˘ 0.83(median ´0.07)
´0.32 ˘ 0.68
(median ´0.21) 0.005
0.07 ˘ 0.81
(median ´0.09)
0.35 ˘ 0.90
(median 0.23) <0.001
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Table 1. Population characteristics, dietary intakes and cardiometabolic factors of Raine Study
adolescents at 14- and 17-year follow-ups.
Mean ˘ SD or n (%)
Girls (n = 461)
p
Boys (n = 399)
pFollow-up Year Follow-up Year
14 17 14 17
Reporting status
Under-reporter 161 (34.9) 221 (47.9)
<0.001
46 (11.5) 65 (18.5)
0.03Plausible-reporter 237 (51.4) 171 (37.1) 256 (64.2) 228 (65.0)
Over-reporter 14 (3.0) 7 (1.5) 60 (15.0) 58 (16.5)
Cardiometabolic factors
Diastolic blood pressure (mmHg) 59 ˘ 7 60 ˘ 6 0.10 59 ˘ 7 59 ˘ 7 0.33
Systolic blood pressure (mmHg) 109 ˘ 9 110 ˘ 10 0.14 114 ˘ 11 119 ˘ 10 <0.001
HDL-cholesterol (mmol/L) 1.44 ˘ 0.32 1.42 ˘ 0.31 0.19 1.37 ˘ 0.29 1.22 ˘ 0.24 <0.001
LDL-cholesterol (mmol/L) 2.36 ˘ 0.59 2.39 ˘ 0.61 0.36 2.26 ˘ 0.67 2.22 ˘ 0.67 0.15
Total cholesterol (mmol/L) 4.27 ˘ 0.63 4.26 ˘ 0.71 0.85 4.05 ˘ 0.73 3.91 ˘ 0.74 <0.001
Total:HDL-cholesterol ratio 3.11 ˘ 0.81 3.12 ˘ 0.71 0.80 3.05 ˘ 0.74 3.32 ˘ 0.84 <0.001
Triglycerides (mmol/L) 1.02 ˘ 0.41 1.00 ˘ 0.42 0.36 0.91 ˘ 0.45 1.03 ˘ 0.57 0.001
Glucose (mmol/L) 4.68 ˘ 0.39 4.62 ˘ 0.92 0.011 4.86 ˘ 0.38 4.78 ˘ 0.49 0.002
Insulin (mU/L) 11.9 ˘ 6.66(median 10.5)
9.77 ˘ 14.4
(median 8.34) 0.003
11.1 ˘ 8.12
(median 9.50)
8.57 ˘ 6.62
(median 7.16) <0.001
HOMA-IR d
2.50 ˘ 1.57
(median 2.18)
2.07 ˘ 3.60
(median 1.69) 0.025
2.45 ˘ 2.15
(median 2.01)
1.85 ˘ 1.53
(median 1.51) <0.001
CRP (mg/L) 1.68 ˘ 5.27(median 0.48)
2.39 ˘ 4.48
(median 0.66) 0.12
1.24 ˘ 1.99
(median 0.52)
1.31 ˘ 1.96
(median 0.40) 0.72
MetS IDF e (yes) 20 (4.3) 15 (3.3) >0.99 11 (2.8) 9 (2.3) >0.99
Cohort MetS cluster f (high risk) 103 (22.3) 59 (12.8) <0.001 64 (16.0) 39 (9.8) 0.004
Percentages may not add to 100% if values were missing; p-values for paired t-tests or McNemar tests; NA
Test not applicable, or test not valid due to insufficient data; AUD = Australian dollars; BMI = body mass
index; CRP = C-reactive protein; LDL = low density lipoprotein; HDL = high density lipoprotein; a The physical
working capacity test at a heart rate of 170 beats per minute (PWC170) was used to estimate aerobic fitness;
b Reduced fat classifications: milk < 3 g fat/100 mL, cheese < 16 g fat/100 g, butter < 50 g fat/100 g,
ice-cream < 7 g fat/100 g, yoghurt < 3 g fat/100 g, dairy dessert/custard < 3 g fat/100 g, cream < 30 g fat/100 g;
c Dietary patterns previously identified in the Raine cohort that can be considered to be a measure of overall
dietary quality—the healthy pattern is characterized by high intakes of fiber and micronutrients, while the
Western dietary pattern is characterized by high intakes of fat, saturated fat, cholesterol and refined sugars [19];
d Homeostasis model assessment for insulin resistance (HOMA-IR) [25,26]; e Metabolic syndrome as defined by
the International Diabetes Federation (IDF) paediatric criteria [27]; f Cohort based categorization into “high or
low metabolic syndrome risk” groups derived using cluster analysis [28].
Further dietary aspects considered from the FFQ for analyses in this study were total daily energy
intake and two major dietary patterns previously identified in the Raine cohort that can be considered
to be an estimate of overall dietary quality. These patterns, defined as “healthy” and “Western”,
were identified at the 14- and 17-year follow-ups through factor analysis [19]. The healthy pattern is
characterized by high intakes of fiber and micronutrients, whereas the Western is characterized by
high intakes of fat, saturated fat, cholesterol and refined sugars. As adolescents who consume reduced
fat dairy may differ in other dietary habits to those who consume regular fat dairy, this additional
information assisted to partially account for these differences. In addition, the ratio of reported energy
intake relative to the estimated energy requirement was used to classify potential under, plausible or
over-reporters based on the Goldberg method, as previously described [29]. Rather than excluding
possible under or over-reporters, this categorical variable was considered as a potential confounder in
statistical models [30].
2.3. Metabolic Syndrome and Cardiometabolic Risk Factor Assessments
We chose to use both the International Diabetes Federation (IDF) paediatric criteria [27],
as recommended by the American Heart Association [31], and a cohort based categorization into
“high or low metabolic risk” groups derived using cluster analysis [28] to define metabolic syndrome
(MetS). IDF criteria require a high waist circumference in addition to at least two of the following: high
fasting serum triglycerides; low fasting serum high-density lipoprotein (HDL) cholesterol; high systolic
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or diastolic blood pressure (BP); or high fasting plasma glucose concentrations. Thresholds for high or
low subgroups vary by gender and age as published previously [27]. The two-step cluster analysis
utilized anthropometric, BP, and lipid assessments, along with the homeostasis model assessment
for insulin resistance (HOMA-IR) [25,26] to determine natural groupings in the data and maximize
within-group similarities and between-group differences. Analyses were performed separately by
gender [28], with adolescents grouped into either a high-risk metabolic cluster or a low-risk metabolic
cluster. At both 14- and 17-years, membership of the high-risk cluster was significantly associated with
increased systolic and diastolic BP, waist circumference, fasting insulin, glucose and HOMA-IR, fasting
triglycerides, and low-density lipoprotein (LDL) cholesterol, and lower HDL-cholesterol compared
with adolescents in the low-risk metabolic cluster [32].
Trained researchers measured waist circumference to the nearest 0.1 cm at the level of
the umbilicus until two readings were within a centimetre of each other. Weight was measured
to the nearest 100 g using a Wedderburn Digital Chair Scale, and height to the nearest 0.1 cm using
a Holtain Stadiometer. Body mass index (BMI) was calculated as weight in kilograms divided by
height in metres squared. Waist to height ratio was used as an indicator of abdominal obesity [33].
BP measurements were taken after a five-minute rest using a Dinamap ProCare 100 automatic
oscillometric recorder (GE Healthcare Technologies, Rydalmere, Australia). The appropriate cuff for
body size was used and placed on the right arm. BP readings were obtained in the seated position at
14 years and in the supine position at 17 years. Six measurements were taken over 10 min; the first was
disregarded and the mean of the next five measurements was calculated.
Phlebotomists visited adolescents at home early in the morning to obtain fasting blood samples.
PathWest Laboratories at Royal Perth Hospital conducted the assays [28]. Serum total cholesterol
and triglycerides were determined enzymatically on the Cobas MIRA analyser (Roche Diagnostics,
Basel, Switzerland) with reagents from Trace Scientific (Melbourne, Australia). HDL cholesterol was
determined on a heparin-manganese supernatant. Serum glucose was measured with an automated
Technicon Axon Analyzer (Bayer Diagnostics, Sydney, Australia) by using a hexokinase method.
Serum insulin was measured by radioimmunoassay with an automated immunoassay analyzer
(Tosoh Corporation, Tokyo, Japan). Glucose and insulin values were used to derive HOMA-IR, a measure
of insulin resistance [25,26]. C-reactive protein (CRP), a marker of inflammation in the body, was assessed
using a high-sensitivity monoclonal antibody assay (Dade Behring Marburg, Marburg, Germany).
2.4. Additional Assessments
The primary caregiver provided sociodemographic information including family structure, family
income, family medical history, parental age and employment at the 14- and 17-year follow-ups.
The mother or primary caregiver also provided information on early infant feeding, including
breastfeeding and solids, during the first years of life. The physical working capacity test at a heart rate
of 170 beats per minute (PWC170) was used to estimate aerobic fitness at both time points. This test
has been shown to be a valid predictor of VO2max in adolescents [34].
2.5. Statistical Analysis
Subjects with extreme daily energy intakes were excluded (<3000 or >20000 kJ/day, as previously
used in adolescent studies [21,35]. Baseline characteristics were summarized using means and standard
deviations (SDs) for continuous measures and percentages for categorical variables. Medians were
included for markedly skewed measures. Paired t-tests and McNemar tests were used to determine
differences in the characteristics between the 14-and 17-year follow-ups. Paired t-tests were also used
to evaluate differences in regular and reduced fat dairy intake in groups classified as high or low
metabolic risk.
Generalized estimating equations (GEEs) were used to examine associations between dietary
intakes with the MetS as defined by IDF adolescent specific criteria and the cohort metabolic cluster,
and related metabolic factors. By taking correlation into account, GEEs allowed the data from both
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follow-ups to be used [36]. Potential confounding factors were investigated for inclusion in models
depending on statistical significance, model fit and colinearity. Regular fat dairy (serves/day) and
reduced fat dairy (serves/day) were considered together as explanatory variables in models that
were initially adjusted for age, total daily energy intake and dietary misreporting status. Regular and
reduced fat dairy were included together to account for the likelihood that some adolescents would
have a lower regular fat dairy intake due to consuming predominantly reduced fat dairy, and vice-versa
(correlation between regular and reduced fat dairy was ´0.45 at 14 years and ´0.31 at 17 years).
Dietary intake of total dairy (serves/day) was also considered in separate models. All models were
further adjusted for aerobic fitness, maternal age, ever breastfed (yes/no), and healthy and Western
dietary pattern z-scores. Models of CRP, HOMA-IR, LDL-cholesterol, HDL-cholesterol, blood pressure
and the ratio of total to HDL cholesterol were additionally adjusted for BMI.
For the binary response variables IDF and cohort cluster MetS, the models’ odds ratios (ORs),
and 95% confidence intervals (CIs), estimate the factor change in odds of having the syndrome
associated with an increase in consumption of one serve of dairy. Variables that were not normally
distributed, such as waist-height ratio, CRP, HOMA-IR, HDL-cholesterol, LDL-cholesterol and the total:
HDL-cholesterol ratio were log transformed and model estimates were interpreted as the percentage
(factor) change in each measure associated with an increase in consumption of one serve of dairy.
Systolic and diastolic BPs were not skewed, and model coefficients (B) provide the mean change in
pressure with a one serve increase in consumption. Data were analysed using IBM SPSS Statistics
(Version 21.0) [37] and statistical significance was set at 5%. No mathematical correction was made for
testing multiple associations, instead all results including 95% CIs, and p-values < 0.05 are reported.
3. Results
FFQs were completed by 1631 adolescents at the 14-year follow-up and 1009 at 17-years,
with 860 (46.4% male) providing usable dietary data from both follow-ups. Of these, 582 also had
blood biochemistry at both follow-ups, although more had physical measures or at least one blood
assessment. Characteristics, dietary intakes and cardiometabolic variables are reported in Table 1.
Detailed information on dairy intake for this cohort has been published previously [15]. Differences
in Raine Study adolescents participating in dietary assessment have been previously reported to
be higher family income, older mothers, and a lower BMI than those adolescents who chose not to
participate in this aspect of the longitudinal study [21,38,39]. Mean intakes of low and regular fat
dairy by MetS status are displayed in Figures 1 and 2. In boys in the low-risk metabolic cluster, mean
intakes of regular fat products at both 14 and 17 years were significantly higher than intakes of reduced
fat products (paired t-tests, p < 0.001 and p = 0.001, respectively). Results were similar for boys who
did not have MetS as defined by IDF criteria (p = 0.005 and p = 0.008, respectively). In boys in the
high-risk metabolic cluster and those with MetS as defined by IDF criteria, mean intakes of regular
fat products at 14 and 17 years were lower than intakes of reduced fat products, but the differences
were not significant. Intakes in girls were similar between MetS risk groups, with regular fat dairy at
17 years showing the lowest level of intake in both high and low risk groups.
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Figure 1. Mean intake of reduced fat and regular fat dairy (serves/day) in girls and boys over the 14 and 17-
year follow-ups, according to metabolic cluster status at the 17-year follow-up. In boys in the low-risk 
metabolic cluster, mean intakes of regular fat products at both 14 and 17 years were significantly higher than 
intakes of reduced fat products (paired t-tests, P<0.001 and P=0.001, respectively). a Reduced fat classifications: 
milk < 3g fat/ 100 ml, cheese < 16 g fat/ 100 g, butter < 50 g fat/ 100 g, ice-cream < 7g fat/ 100g, yoghurt < 3g fat/ 
100g, dairy dessert/custard < 3g fat/ 100g, cream < 30 g fat/ 100 g; b Classification as high or low metabolic risk 
based on cluster analysis in the cohort [28].   
 
Figure 2. Mean intake of reduced fata and regular fat dairy (serves/day) in girls and boys over the 14 and 17-
year follow-ups, according to metabolic syndrome status at the 17 year follow up. In boys who did not fit the 
 
Figure 1. ean intake of reduced fat and regular fat dairy (serves/day) in girls and
boys over the 14 and 17-year follow- ps, according to metabolic cluster status at the 17-year
follow-up. In boys in the low-risk metabolic cluster, mean intakes of regular fat products at
both 14 and 17 years were significantly higher than intakes of reduced fat products (paired t-tests,
p < 0.001 and p = 0.001, respectively). a Reduced fat classifications: milk < 3 g fat/100 mL,
cheese < 16 g fat/100 g, butter < 50 g fat/100 g, ice-cream < 7 g fat/100 g, yoghurt < 3 g fat/100 g,
dairy dessert/custard < 3 g fat/100 g, cream < 30 g fat/100 g; b Classification as high or low metabolic
risk based on cluster analysis in the cohort [28].
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Figure 2. Mean intake of reduced fata and regular fat dairy (serves/ ay) in girls and boys over
the 14 and 17-year follow-ups, according to me abolic synd ome status at the 17 year follow up.
In boys who did not fit the metabolic syndrome criteria, mean intakes of regular fat products at
both 14 and 17 years were significantly higher than intakes of reduced fat products (paired t-tests,
p = 0.005 and p = 0.008, respectively). a Reduced fat classifications: milk < 3g fat/100 mL,
cheese < 16 g fat/100 g, butter < 50 g fat/100 g, ice-cream < 7 g fat/100 g, yoghurt < 3g fat/100 g,
dairy dessert/custard < 3 g fat/100 g, cream < 30 g fat/100 g; b According to the International Diabetes
Federation (IDF) adolescent specific criteria [27].
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GEE model estimates are presented in Tables 2 and 3. Although there was a 2% reduction in the
total: HDL-cholesterol ratio for each serve of total dairy intake in girls (95% CI 0.97–0.99; p = 0.038)
in the model adjusted for age, kilojoule intake and reporting bias, the reduction was not significant
in the fully adjusted model. In boys, after full adjustment, there was a decrease in mean diastolic
BP of 0.54 mmHg (95% CI 0.17–0.92; p = 0.004) along with a decrease in HDL-cholesterol of 1%
(95% CI 0.98–0.998; p = 0.008) per total dairy serve (Table 2).
Table 3 presents the explanatory effects when total dairy intake was divided into reduced fat
and regular fat components. Low and regular fat dairy intakes both displayed similar associations
with cardiometabolic risk factors. In boys, a significant reduction in diastolic BP was associated
with both reduced fat and regular fat dairy consumption. After full adjustment, there was a mean
reduction in diastolic BP of 0.66 mmHg (95% CI 0.23–1.09; p = 0.002) per serve of reduced fat dairy
and an independent, additional reduction of 0.47 mmHg (95% CI 0.04–0.90; p = 0.034) per serve of
regular fat dairy. The only other significant association in boys after full adjustment was that for each
additional serve of reduced fat dairy there was a 2% reduction in HDL-cholesterol (95% CI 0.97–0.995;
p = 0.005) and a 2% increase in the total: HDL-cholesterol ratio (95% CI 1.002–1.03; p = 0.023); this was
not observed with regular fat products. In addition, waist to height ratio was significantly inversely
associated with regular fat dairy after partial (OR 0.993, 95%CI 0.988–999, p = 0.014) but not full
adjustment for potential confounding factors. In girls, the only significant association was that for
each additional serve of regular fat dairy there was a 2% decrease in the total: HDL-cholesterol ratio
(95% CI 0.97, 0.99; p = 0.013) in the model adjusted for age, kilojoule intake and reporting status,
but this association did not remain significant after full adjustment. No significant associations were
observed with metabolic syndrome and dairy intakes for boys or girls.
Table 2. Multivariable explanatory effects of total dairy intake (serves/day) on cardiometabolic
risk factors.
Outcomes
Girls Model 1 a Girls Model 2 b Boys Model 1 Boys Model 2
OR c or B d (95% CI) OR or B (95% CI) OR or B (95% CI) OR or B (95% CI)
IDF met 0.72 (0.48, 1.08) 0.74 (0.48, 1.13) 0.88 (0.58, 1.35) 0.98 (0.61, 1.58)
Cluster met 0.98 (0.83, 1.15) 0.87 (0.71, 1.07) 1.13 (0.94, 1.35) 1.09 (0.90, 1.33)
Waist: height 1.00 (0.99, 1.00) 1.00 (0.99, 1.01) 1.00 (0.99, 1.00) 1.00 (0.99, 1.01)
CRP 1.00 (0.90, 1.12) 1.05 (0.94, 1.18) 0.99 (0.93, 1.07) 1.02 (0.95, 1.10)
HOMA-IR 0.97 (0.93, 1.02) 1.03 (0.98, 1.08) 0.97 (0.94, 1.01) 0.99 (0.95, 1.03)
HDL 1.01 (0.99, 1.03) 1.01 (0.99, 1.03) 0.99 (0.98, 1.001) 0.99 (0.98, 0.998) *
LDL 0.99 (0.97, 1.00) 0.99 (0.97, 1.01) 1.00 (0.99, 1.02) 1.00 (0.98, 1.01)
Total: HDL 0.98 (0.97, 0.999) * 0.99 (0.97, 1.01) 1.01 (0.99, 1.02) 1.01 (1.00, 1.02
SBP 0.40 (´0.33, 1.14) 0.56 (´0.25, 1.36) ´0.25 (´0.84, 0.35) ´0.45 (´1.04, 0.13)
DBP ´0.13 (´0.76, 0.29) ´0.12 (´0.65, 0.40) ´0.51 (´0.84, ´0.19) * ´0.54 (´0.92, ´0.17) *
IDF met = classified as having metabolic syndrome according to the International Diabetes Federation (IDF)
adolescent specific criteria [27]; Cluster met = classified as being in the high metabolic risk cluster based
on cluster analysis in the cohort [28]; CRP = C-reactive protein (mg/L); HOMA-IR = homeostasis model
assessment for insulin resistance [25,26]; HDL = high density lipoprotein cholesterol (mmol/L); LDL = low
density lipoprotein cholesterol (mmol/L); SBP = systolic blood pressure (mmHg); DBP = diastolic blood pressure
(mmHg); * = p < 0.05; a Model 1 adjusted for age, kilojoule intake and reporting status; b Model 2 further
adjusted for aerobic fitness, maternal age, BMI, ever breastfed (yes/no), and healthy and Western dietary pattern
scores, except models of MetS IDF, MetS cluster, and waist-height ratio, which did not include adjustment
for BMI; c IDF & cluster met—odds ratio (OR) is the factor change in odds of being classified as having MetS
(defined by those criteria) associated with a one serve increase in total dairy consumption; waist-height ratio,
CRP, HOMA-IR, HDL- and LDL-cholesterol, and total: HDL cholesterol ratio—percentage (factor) change
in each measure associated with a one serve increase in total dairy consumption. The change is statistically
significant at the 5% level if the 95% CI excludes one (these response variables were logged for modelling);
d SBP, DBP—coefficient (B) is mean change in pressure with a one serve increase in total dairy consumption.
The change is statistically significant at the 5% level if the 95% CI excludes zero.
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Table 3. Multivariable explanatory effects of reduced and regular fat dairy intakes (serves/day) on
cardiometabolic risk factors.
Outcome Model
Reduced Fat Regular Fat
OR c or B d (95% CI) OR e or B f (95% CI)
Girls
IDF met
1 a 0.75 (0.49, 1.14) 0.67 (0.39, 1.13)
2 b 0.79 (0.50, 1.25) 0.66 (0.38, 1.15)
Cluster met
1 0.97 (0.81, 1.15) 1.00 (0.79, 1.26)
2 0.84 (0.68, 1.04) 0.95 (0.72, 1.24)
Waist: height 1 1.00 (0.99, 1.01) 0.99 (0.986, 1.00)
2 1.00 (0.99, 1.01) 1.00 (0.99, 1.01)
CRP
1 1.01 (0.91, 1.13) 0.97 (0.84, 1.12)
2 1.08 (0.96, 1.21) 0.98 (0.84, 1.14)
HOMA-IR
1 0.97 (0.92, 1.02) 0.98 (0.92, 1.03)
2 1.02 (0.97, 1.07) 1.04 (0.99, 1.10)
HDL
1 1.01 (0.99, 1.03) 1.02 (0.99, 1.05)
2 1.00 (0.98, 1.02) 1.01 (0.99, 1.04)
LDL
1 0.98 (0.96, 1.00) 0.99 (0.97, 1.02)
2 0.99 (0.97, 1.01) 0.99 (0.97, 1.02)
Total: HDL
1 0.98 (0.97, 0.99) * 0.98 (0.96, 1.00)
2 0.99 (0.97, 1.01) 0.98 (0.96, 1.01)
SBP
1 0.61 (´0.17, 1.38) ´0.09 (´0.99, 0.81)
2 0.73 (´0.13, 1.59) 0.20 (´0.77, 1.18)
DBP
1 ´0.14 (´0.61, 0.33) ´0.11 (´0.72, 0.51)
2 ´0.13 (´0.67, 0.41) ´0.11 (´0.79, 0.58)
Boys
IDF met
1 1.01 (0.65, 1.57) 0.62 (0.25, 1.51)
2 1.22 (0.67, 2.21) 0.73 (0.31, 1.67)
Cluster met
1 1.03 (0.84, 1.25) 1.24 (1.00, 1.55)
2 0.97 (0.77, 1.22) 1.19 (0.93, 1.51)
Waist: height 1 1.00 (0.99, 1.01) 0.993 (0.988, 0.999) *
2 1.01 (1.00, 1.01) 0.996 (0.99, 1.00)
CRP
1 1.01 (0.94, 1.10) 0.98 (0.91, 1.06)
2 1.04 (0.96, 1.13) 1.01 (0.94, 1.10)
HOMA-IR
1 0.97 (0.93, 1.02) 0.97 (0.93, 1.01)
2 0.98 (0.93, 1.02) 0.99 (0.95, 1.04)
HDL
1 0.99 (0.98, 0.999) * 1.00 (0.99, 1.01)
2 0.98 (0.97, 0.995) * 0.99 (0.98, 1.00)
LDL
1 1.00 (0.98, 1.01) 1.00 (0.99, 1.02)
2 1.00 (0.98, 1.02) 1.00 (0.98, 1.02)
Total: HDL
1 1.01 (1.00, 1.02) 1.00 (0.99, 1.01)
2 1.02 (1.002, 1.03) * 1.01 (1.00, 1.02)
SBP
1 0.01 (´0.71, 0.74) ´0.43 (´1.07, 1.78)
2 ´0.52 (´1.24, 0.20) ´0.41 (´1.04, 0.22)
DBP
1 ´0.56 (´0.96, ´0.17) * ´0.47 (´0.84, ´0.10) *
2 ´0.66 (´1.09, ´0.23) * ´0.47 (´0.90, ´0.04) *
Reduced fat classifications: milk < 3g fat/100 mL, cheese < 16 g fat/100 g, butter < 50 g fat/100 g,
ice-cream < 7 g fat/100 g, yoghurt < 3 g fat/100 g, dairy dessert/custard < 3 g fat/100 g, cream < 30 g fat/100 g;
IDF met = classified as having metabolic syndrome as defined by the International Diabetes Federation (IDF)
paediatric criteria [27]; Cluster met = classified as being in the high metabolic risk cluster based on cluster
analysis in the cohort [28]; CRP = C-reactive protein (mg/L); HOMA-IR = homeostasis model assessment for
insulin resistance [25,26]; HDL = high density lipoprotein cholesterol (mmol/L); LDL = low density lipoprotein
cholesterol (mmol/L); SBP = systolic blood pressure (mmHg); DBP = diastolic blood pressure (mmHg); * p < 0.05;
Reduced fat and regular fat dairy products (serves/day) are included in the models together; a Model 1 adjusted
for age, kilojoule intake and reporting status; b Model 2 further adjusted for aerobic fitness, maternal age, BMI,
ever breastfed (yes/no), and healthy and Western dietary pattern scores, except models of MetS IDF and MetS
cluster which did not include adjustment for BMI; c IDF & cluster met—odds ratio (OR) is the factor change
in odds of being classified as having MetS (defined by those criteria) associated with a one serve increase
in reduced fat dairy consumption (adjusted for regular fat dairy consumption); CRP, HOMA-IR, HDL- and
LDL-cholesterol, and total: HDL-cholesterol ratio—percentage (factor) change in each measure associated with
a one serve increase in reduced fat dairy consumption (adjusted for regular fat dairy consumption). The change
is statistically significant at the 5% level if the 95% CI excludes one; d SBP, DBP—coefficient (B) is mean change in
pressure with a one serve increase in reduced fat dairy consumption (adjusted for regular fat dairy consumption).
The change is statistically significant at the 5% level if the 95% CI excludes zero; e IDF & cluster met—odds
ratio (OR) is the factor change in odds of being classified as having MetS (defined by those criteria) associated
with a one serve increase in regular fat dairy consumption (adjusted for reduced fat dairy consumption);
CRP, HOMA-IR, HDL- and LDL-cholesterol, and total: HDL-cholesterol ratio—percentage (factor) change in
each measure associated with a one serve increase in regular fat dairy consumption (adjusted for reduced fat
dairy consumption). The change is statistically significant at the 5% level if the 95% CI excludes one; f SBP,
DBP—coefficient (B) is mean change in pressure with a one serve increase in regular fat dairy consumption
(adjusted for reduced fat dairy consumption). The change is statistically significant at the 5% level if the 95% CI
excludes zero.
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4. Discussion
This study provides a unique contribution to the dairy literature by comparing reduced fat and
regular fat product intake with cardiometabolic risk factors, in girls and boys, over the period from
early to late adolescence. Adolescence is an important period of growth and development and it is
valuable to have investigations specific to this group. Overall, intakes of both regular and reduced
fat dairy products during adolescence were similarly associated with cardiometabolic risk factors
after adjustment for potential confounding factors. In accordance with our hypothesis, regular fat
dairy product intake was not associated with increased cardiometabolic disease risk. Both low and
regular fat dairy were inversely associated with diastolic BP in boys, with one serve equating to a small
decrease of approximately 0.5 mmHg. In addition, reduced fat dairy intake was inversely associated
with HDL-cholesterol, but the association was small. In girls, however, there were no significant
associations after potential confounding factors were taken into account.
Boys in the low-risk metabolic groups in late adolescence consumed higher mean intakes of regular
fat than reduced fat dairy products in early and late adolescence. Likewise, in the high-risk metabolic
groups in late adolescence, both boys and girls consumed less regular fat dairy compared to reduced
fat. However, there were no significant differences when modelled with potential confounding factors.
The beneficial association we observed with dairy and BP is supported by previous studies.
Higher intakes of dairy (ě two serves/day) have been associated with lower BP in children [40–42],
although regular and reduced fat dairy were not compared. A longitudinal study of adolescents
found that increasing dairy intake was associated with decreases in BP for girls, particularly for cheese
(generally a higher fat dairy product) [43]. Our results suggest the beneficial effects of dairy on BP in
youth may not differ by fat content. In adults, reduced fat dairy may be more effective, but results
are inconsistent [44]. Overall, there is a strong likelihood that dairy consumption benefits BP [45],
potentially due to factors outside fat content. High protein, calcium and potassium, low sodium
and bioactive lactotripeptides found in dairy may influence BP through a variety of mechanisms
including via effects on nitric oxide, endothelial function, vasodilation, arterial stiffness, and water
retention [44]. In our study, significant associations with BP were only seen in boys, which may suggest
a gender-related increased sensitivity to these effects or the existence of a threshold, given that intake
of dairy was higher in boys.
We found three published studies that have compared regular and reduced fat dairy intake with
MetS or metabolic related outcomes in adolescence: Te Velde et al. followed Dutch adolescents to
adulthood [46]; Malik et al. [47], retrospectively examined adolescent intakes recalled from high school
years and compared them with adult outcomes in The Nurses’ Health Study II, and Mohammadi et al.,
conducted cross-sectional investigations of Iranian adolescents [48]. Te Velde et al., showed that
participants with at least two MetS risk factors at 36 years of age had consumed more reduced fat
and less regular fat dairy at 21 years, but observed no significant associations with earlier adolescent
intake [46]. The study did not examine males and females separately, likely due to sample size
limitations. In The Nurses’ Health Study II, consumption of regular but not reduced fat dairy
products in adolescence was inversely associated with later development of type 2 diabetes, although
both low and regular fat consumption were inversely associated when the women were examined
cross-sectionally as middle aged adults [47]. Mohammadi et al. [48] found no significant associations
with MetS for either reduced fat or regular fat dairy, with girls and boys grouped together for analysis.
Similar results were found in a large multi-cohort study of US adults, in which neither reduced fat
or regular fat dairy intake was significantly associated with risk of type 2 diabetes [49]. Meta-analyses
in adults also found that intake of regular fat dairy was not significantly associated with increased risk
of type 2 diabetes [50], hypertension [51,52] or cardiovascular disease [53], although reduced fat dairy
was found to be significantly inversely associated with risk in each of these studies. Intake of cheese,
despite being a higher fat dairy product, was also found to be significantly inversely associated with
risk in some of these meta-analyses [50,53].
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Taken together with our findings, existing observational evidence suggests that intake of regular
fat dairy is not associated with increased metabolic or cardiovascular risk. However, these studies do
not represent cause and effect. Some people at higher risk of poor health outcomes may have chosen
reduced fat dairy products specifically due to their risk status. Randomized trials can address this
limitation. Benatar et al. [54] conducted a meta-analysis of randomized trials in adults that increased
dairy intake using either reduced fat or regular fat products for at least one month. Overall, results were
similar between reduced and regular fat products, with modest weight gain and with no or minor
effects on other cardiometabolic risk factors. However, none of the trials in this meta-analysis directly
compared the effects of reduced fat with regular fat dairy.
In our study, increasing intake of reduced fat but not regular fat dairy showed a small association
with lower HDL-cholesterol and a higher total: HDL-cholesterol ratio in boys. Along the same
lines, low but not regular fat dairy was associated with a lower total: HDL-cholesterol ratio in
girls; however, this association was not significant after full adjustment. As higher HDL-cholesterol
values are associated with improved cardiovascular risk [55], this finding suggests that regular fat
dairy is associated with a slightly more beneficial lipid profile. This association may be due to
additional fatty acids provided by regular fat dairy products improving HDL-cholesterol. Saturated
fat can increase total and LDL-cholesterol, but it may also increase HDL-cholesterol [56]. Lower fat
dairy intakes may therefore result in marginally lower HDL-cholesterol along with LDL-cholesterol.
Short term diets high in regular fat milk and butter have been shown to increase both LDL- and
HDL-cholesterol, with minimal change or even improvement to the total: HDL-cholesterol ratio [57].
Higher HDL-cholesterol has numerous beneficial functions within the cardiovascular system, including
removal of cholesterol from blood vessel walls, assisting in blood vessel dilation and reducing injury
to blood vessels [58].
Changing the type of dairy product consumed is likely to have flow on effects to other parts of
the diet. A randomized controlled trial investigating changing children’s consumption from regular
fat to reduced fat dairy foods found that although saturated fat intake was reduced, overall energy
intake remained similar, suggesting the energy from saturated fat was replaced by other sources [59].
Resulting health effects are likely to depend on what replaces saturated fat—polyunsaturated fat,
but not carbohydrate, has been associated with a reduction in coronary heart disease [60]. Given that
research suggests energy intakes tend to remain similar in children, consumption of regular fat dairy
products in place of reduced fat products may potentially decrease the amount of refined carbohydrate
snack foods eaten by children and adolescents. Intakes of these foods are likely to be high in some
adolescents, with an Australian study reporting that over forty per cent of adolescent daily food energy
comes from confectionery, biscuits, cakes and other products which fall outside the core groups of
fruit, vegetables, meat and alternatives, dairy and grains [61].
It is also important to remember that people consume whole foods rather than separate nutrients.
Foods containing saturated fat may have varying effects on health due to other nutrients or bioactive
properties in the food, as well as different types of saturated fats present. For example, margaric acid
(17.0), a saturated fatty acid moderately correlated with dairy fat consumption, has been significantly
associated with a lower risk of coronary disease [62]. Thus, regular fat dairy products may have
different effects on health compared with other high saturated fat foods [9]. In addition, the fat
composition of the dairy products themselves may differ by farming practices, with fatty acid content
dependent on the cows’ feed. Milk from cows that are predominantly pasture fed, as in Australia,
is likely to have a more beneficial fatty acid profile than milk from grain fed cows [13].
As recommended by some statisticians [63,64], no mathematical correction was made for testing
multiple associations, instead all results are reported. Thus, some of our observed significant
associations may be due to chance. Although the Raine Study is a population-based cohort,
not all subjects completed every aspect of the adolescent follow-ups, and those completing dietary
assessments tended to have relatively lower body mass indices, older mothers and higher family
income [21,38,39]. This therefore limits the generalization of our results to the wider adolescent
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population. Although the FFQ we used was tailored for, and tested in, our adolescent population,
it is only an estimate of intake, given the limitations of self-reporting. To standardize serve sizes,
we used calcium equivalents but this has limitations when analyzing different dairy products, as they
cover such a wide range of nutrient profiles. Dairy foods with lower calcium levels relative to other
nutrients would be potentially underrepresented as a result. A further limitation of this study is that
BP values obtained from sitting and supine positions cannot be assumed to be equivalent, as supine
values tend to be slightly lower [65]. This may mean that the association observed with dairy and BP
is understated, as smaller differences are harder to detect.
An important strength of our study was the ability to adjust for evaluated marks of overall diet
quality [21], as well as energy intake and infant feeding. Other strengths of our study include its
prospective design, the population based sample and use of comprehensive metabolic measures.
Our study of adolescents found that associations between dairy intake and cardiometabolic risk
factors were similar for regular and reduced fat products. Potentially, either reduced fat or regular
fat dairy products may be suitable for healthy development in this age range, and good quality
dietary trials are required in this area. Given that intakes of dairy can often be low in adolescents,
advocating a choice of either regular or reduced fat products may encourage more adolescents to meet
recommended dairy intakes. However, determination of the optimal number of dairy serves also
requires further investigation [66]. We aim to continue our prospective analyses of associations with
cardiometabolic factors as participants in the Raine Cohort enter adulthood. Our interesting findings
with HDL-cholesterol support future development of randomised dietary trials to determine whether
a change to regular fat dairy could potentially benefit adolescent cardiometabolic health.
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